16 results
Traditionally, congestive heart failure has been classified according to severity of symptoms, first formulated by the
to severity of symptoms ... sometimes advanced treatment ... #Diagnosis #Cardiology ... CHF #Congestive #HeartFailure ... #Staging #Classification
In order to better classify heart failure, the American College of Cardiology Foundation and the American
American College of Cardiology ... based solely on symptoms ... With treatment, ... #Diagnosis #Cardiology ... CHF #Congestive #HeartFailure
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
Heart Failure Pathophysiology ... functional ID) Treatment ... improvement in symptoms ... deficiency #CHF #HFrEF #heartfailure ... diagnosis #management #cardiology
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Diagnosis and Treatment ... order to alleviate symptoms ... deficiency #CHF #HFrEF #heartfailure ... management #algorithm #cardiology ... #treatment #guidelines
STAGES of CHF (A, B, C, D), however, describe the severity of structural abnormalities that impair
sometimes advanced treatment ... III and class IV symptoms ... Treatments may include ... #Management #Cardiology ... CHF #Congestive #HeartFailure
Lymphomas and Lymphoproliferative Disorders - Differential Diagnosis Algorithm
Hodgkin Lymphoma ~40% - Characteristic For Reed-Sternberg (RS) Cells
pattern of spread, B symptoms ... Responsive to Treatment ... Lymphoproliferative #Disorders #Classification ... #pathophysiology ... #Hematology #Diagnosis
Leukostasis vs Tumor Lysis Syndrome
Leukostasis:
 • Pathophysiology: Large, immature blasts and high WBC count cause hyperviscosity
Leukostasis: • Pathophysiology ... Dehydration • Symptoms ... changes, stroke symptoms ... Lysis Syndrome: • Pathophysiology ... diagnosis #management #hematology
Symptoms Distinguishing Groups of Cutaneous Drug Reactions
IgE-mediated reactions:
 • Onset minutes to hours into treatment course
Symptoms Distinguishing ... to hours into treatment ... Onset days into treatment ... Drug #Reactions #dermatology ... clinical #comparison #classification
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
blood donor • Pathophysiology ... ARDS to explain symptoms ... : 33% • Treatment ... : No • Treatment ... Transfusion #Reactions #hematology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... Pathophysiology ... Diagnosis: >3 symptoms ... Renal Failure Treatment ... diagnosis #management #hematology